Immunovaccine Inc. (IMMVF) - OTCQX
From other sites
Company Description
Immunovaccine Inc. develops cancer immunotherapies and infectious disease vaccines based on the Company's DeopVax platform, a patented formulation that provides controlled and prolonged exposure of antigens and adjuvant to the immune system. Immunovaccine has advanced two T cell activation... More
Sector: Healthcare
Industry: Biotechnology
Country: Canada